Inflammatory bowel disease (IBD) affects 6.8 million people globally. A variety of factors
have been implicated in IBD pathogenesis, including host genetics, immune dysregulation …

At present chronic liver disease (CLD), the third commonest cause of premature death in the
United Kingdom is detected late, when interventions are ineffective, resulting in …

Background: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative
colitis, is a chronic, inflammatory disorder of the gastrointestinal tract. As the novel …

Background Inflammatory bowel disease (IBD) is a chronic inflammatory immune‐mediated
disorder of the gut with frequent extra‐intestinal complications. Pancreatic involvement in …

The genetics of isolated colonic Crohn's disease place it approximately midway between
Crohn's disease with small intestinal involvement and UC, making a case for considering it …

Inflammatory bowel disease (IBD) is a multisystemic disease, and pancreatic manifestations
of IBD are not uncommon. The incidence of several pancreatic diseases in Crohn's disease …

Traditionally, IBD diagnosis is based on clinical, radiological, endoscopic, and histological
criteria. Biomarkers are needed in cases of uncertain diagnosis, or to predict disease course …

Background Accurate classification of patients with inflammatory bowel disease into the
subtypes ulcerative colitis (UC) and Crohn's disease (CD) is still a challenge, but important …

Background: Autoantibodies against exocrine pancreas (PAb) have been reported to be
pathognomonic markers of Crohn's disease (CD). Recently, the glycoprotein GP2 has been …

Abstract Glycoprotein 2 (GP2) is an autoantigen in Crohn's (CD) and coeliac disease (CeD).
We assessed GP2-isoform (GP2 1–4)-expression in intestinal biopsies of paediatric patients …